Accès gratuit
Numéro
Med Sci (Paris)
Volume 22, Numéro 8-9, Août–Septembre 2006
Page(s) 745 - 750
Section M/S revues
DOI https://doi.org/10.1051/medsci/20062289745
Publié en ligne 15 août 2006
  1. Caucheteux SM, Kanellopoulos-Langevin C, Ojcius DM. At the innate frontiers between mother and fetus : linking abortion with complement activation. Immunity 2003; 18 : 169–72.
  2. Chaouat G, Ledee-Bataille N, Dubanchet S,et al. Reproductive immunology 2003 : reassessing the Th1/Th2 paradigm ? Immunol Lett 2004; 92 : 207–14.
  3. Ledee-Bataille N. Materno-foetal dialogue and human embryo implantation : some evolving concepts. J Gynecol Obstet Biol Reprod 2004; 33 : 564–76.
  4. Moffett A, Loke YW. The immunological paradox of pregnancy : a reappraisal. Placenta 2004; 25 : 1–8.
  5. Hunt J, Petroff M, McIntire R,et al. HLA-G and immune tolerance in pregnancy. FASEB J 2005; 19 : 681–93.
  6. Le Bouteiller P, Pröll J. Immunologie placentaire : le fœtus face à un double défi. Réalités en Gynécologie-Obstétrique 2001; 57 : 9–17.
  7. Morales P, Pace J, Platt J,et al. Placental cell expression of HLA-G2 isoforms is limited to the invasive trophoblast phenotype. J Immunol 2003; 171 : 6215–24.
  8. Solier C, Aguerre-Girr M, Lenfant F,et al. Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast. Eur J Immunol 2002; 32 : 3576–86.
  9. Holmes C, Simpson K, Okada H,et al. Complement regulatory proteins at the feto-maternal interface during human placental development : distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55). Eur J Immunol 1992; 22 : 1579–85.
  10. Xu C, Mao D, Holers VM,et al. A critical role for murine complement regulator crry in fetomaternal tolerance. Science 2000; 287 : 498–501.
  11. Girardi G, Bulla R, Salmon JE,et al. The complement system in the pathophysiology of pregnancy. Mol Immunol 2006; 43 : 68–77.
  12. Aït-Azzouzene D, Gendron M, Houdayer M,et al. Maternal B lymphocytes specific for paternal histocompatibility antigens are partially deleted during pregnancy. J Immunol 1998; 161 : 2677–83.
  13. Contini P, Ghio M, Poggi A,et al. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol 2003; 33 : 125–34.
  14. Pröll J, Bensussan A, Goffin F,et al. Tubal versus uterine placentation : similar HLA-G expressing extravillous cytotrophoblast invasion but different maternal leukocyte recruitment. Tissue Antigens 2000; 56 : 479–91.
  15. Slager HG, Van Inzen W, Freund E,et al. Transforming growth factor-beta in the early mouse embryo : implications for the regulation of muscle formation and implantation. Dev Genet 1993; 14 : 212–24.
  16. Szekeres-Bartho J, Barakonyi A, Par G,et al. Progesterone as an immunomodulatory molecule. Int Immunopharmacol 2001; 1 : 1037–48.
  17. Mellor AL, Munn DH. Tryptophan catabolism prevents maternal T cells from activating lethal anti-fetal immune responses. J Reprod Immunol 2001; 52 : 5–13.
  18. Hunt JS, Vassmer D, Ferguson TA,et al. Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J Immunol 1997; 158 : 4122–8.
  19. Fournel S, Aguerre-Girr M, Huc X,et al. Cutting Edge : Soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 2000; 164 : 6100–4.
  20. Tafuri A, Alferink J, Moller P,et al. T cell awareness of paternal allo-antigens during pregnancy. Science 1995; 270 : 630–3.
  21. Jiang S, Vacchio M. Multiple mechanisms of peripheral T cell tolerance to the fetal allograft. J Immunol 1998; 160 : 3086–90.
  22. Loke YW, King A, Burrows TD. Decidua in human implantation. Hum Reprod 1995; 10 Suppl 2 : 14–21.
  23. Tabiasco J, Rabot M, Aguerre-Girr M,et al. Human decidual NK cells : unique phenotype and functional properties: a review. Placenta 2006; 27(suppl 1) : 34–9.
  24. Le Bouteiller P, Barakonyi A, Giustiniani J,et al. Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity. Proc Natl Acad Sci USA 2002; 99 : 16963–8.
  25. Rabot M, Tabiasco J, Polgar B,et al. HLA Class I/NK cell receptor interaction in early human decidua basalis : possible functional consequences. Chem Immunol Allergy 2005; 89 : 72–83.
  26. Koopman L, Kopcow H, Rybalov B,et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential J Exp Med 2003; 198 : 1201–12.
  27. Kopcow HD, Allan DS, Chen X,et al. Human decidual NK cells form immature activating synapses and are not cytotoxic. Proc Natl Acad Sci USA 2005; 102 : 15563–8.
  28. Avril T, Jarousseau AC, Watier H,et al. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.J Immunol 1999; 162 : 5902–9.
  29. Chumbley G, King A, Robertson K,et al. Resistance of HLA-G and HLA-A2 transfectants to lysis by decidual NK cells. Cell Immunol1994; 155 : 312–22.
  30. Straszewski-Chavez S, Abrahams V, Funai E,et al. X-linked inhibitor of apoptosis (XIAP) confers human trophoblast cell resistance to Fas-mediated apoptosis. Mol Hum Reprod 2004; 10 : 33–41.
  31. Hiby SE, Walker JJ, O’Shaughnessy K M,et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004; 200 : 957–65.
  32. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005; 308 : 1592–4.
  33. Rajagopalan S, Bryceson YT, Kuppusamy SP,et al. Activation of NK Cells by an endocytosed receptor for soluble HLA-G. PLoS Biol 2006; 4 : e9.
  34. Croy BA, He H, Esadeg S, et al. Uterine natural killer cells : insights into their cellular and molecular biology from mouse modelling. Reproduction 2003; 126 : 149–60.
  35. Guimond MJ, Wang B, Croy BA. Engraftment of bone marrow from severe combined immunodeficient (SCID) mice reverses the reproductive deficits in natural killer cell-deficient tg epsilon 26 mice. J Exp Med 1998; 187 : 217–23.
  36. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004; 5 : 266–71.
  37. Sasaki Y, Sakai M, Miyazaki S,et al. Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod 2004; 10 : 347–53.
  38. Fallarino F, Grohmann U, Hwang KW,et al. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 2003; 4 : 1206–12.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.